Stock Market Crash: 3 FTSE 100 shares I’m buying at a bargain

The stock market crash is a rare opportunity to buy high-quality FTSE 100 stocks at a bargain that we might not see again. 

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

If you thought the stock market crash was over, think again. It’s true that the FTSE 100 index has recovered quite a bit from the sub-5,000 bottom it reached in late March. But it’s still a long way off from where it started 2020.

With the coronavirus crisis still underway, I think it’s safe to expect more stock market volatility in the next few months. 

Solving pressing problems

That shouldn’t deter me from investing, however. On the contrary, high-quality FTSE 100 stocks are now available on bargain. I wouldn’t miss buying them now.

Pharmaceuticals company GlaxoSmithKline (LSE: GSK) is one example. Its share price has recovered quite a bit from the lowest it touched, but it’s still at an over 15% discount compared with the highest levels seen in 2020. It announced yesterday that it’s collaborating with Sanofi, the French pharmaceuticals company, to develop Covid-19 vaccines.

If this goes well, it could hold GSK in good stead over the long term. Its financial position is healthy and it’s also a dividend-paying stock. Its current dividend yield at 5.1% is a shade better than the 4.9% for the FTSE 100 as a whole. As a defensive stock, it’s an attractive buy during a slowdown anyway, but in a health crisis it’s even more so.

Providing essentials

The FTSE 100 British-Dutch consumer goods giant Unilever (LSE: ULVR) is another stock I like. Like GSK, it has seen a sharp share price drop in the stock market crash, but has recovered a fair bit. Going by past trends, though, I reckon the share price can rise much from here.

Unilever’s price-to-earnings ratio (P/E), at 16.3 times, makes it a reasonable buy, compared to another consumer goods stock, Diageo, which has a P/E of 20.3 times. It’s also a dividend-paying stock, even though its yield is muted. At 3.4%, it’s below that of the FTSE 100. But the fact that it’s likely to be safer than many others could make up for this.

Untouched and lucrative FTSE 100 stock

Potentially debatable for ethical reasons, but a good income stock otherwise, Imperial Brands is another FTSE 100 share I’ve long liked. The tobacco biggie has an impressive dividend yield of 12.7%. While it’s been saying for sometime that it could cut dividends, it’s not yet done so. In fact, its Covid-19 update is reassuring. It said that there’s been “no material impact” on the business so far.

At a time when many businesses are suffering, this defensive stock looks like a safe haven. And it’s still trading at an almost 21% discount from the highs seen in January this year, having fallen as the stock market crash started. 

All these stocks offer good long-term potential, not just because they have a past history of delivering to investors but because they give us something to look forward to. I’d think that investing in them today will hold us in good stead over time, stock market crash or not. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended Diageo and Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »